Testing effectiveness (Phase 2)Study completedNCT00655785
What this trial is testing
Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)
Who this might be right for
Pancreatic Cancer
Fukushima Medical University 17